GenoScreen
From 30 june to 3 july 2019
Annual Congress of the European Society of Mycobacteriology
Meet us at the Annual Congress of the European Society of Mycobacteriology (ESM), from June 30 to July 3, 2019 in Valencia, Spain.
June 28, 2019
Scientific day of the French Faecal Transplantation Group, Paris
Meet us at the the 3rd scientific day of the French Faecal Transplantation Group (GFTF) on June 28th at the VILMER amphitheatre - Robert Debré Hospital, Paris.
More information (in french)
From June 26 to 28, 2019
Mycobacteria 2019 congress, Angers
Meet us at the Mycobacteria 2019 congress in Angers on June 26, 27 and 28, 2019.
For more details (in french)
June 25 and 26, 2019
MedFIT 2019, Lille
Meet us at MedFIT, June 25 and 26, 2019 in Lille.
from 14 to 16 May 2019
IDSA adebiotech conference, Biocitech Romainville - Grand Paris
Meet us at the conference on "Sustainable Inputs at the service of agricultural, urban and periurban soils" (IDSA) organized by adebiotech, from 14 to 16 May 2019.
For more details (in french)
April 30, 2019
workshop on antimicrobial resistance, Villeneuve d'Ascq
Meet us at the workshop on antimicrobial resistance, organized at the Charles Viollette Institute in Villeneuve d'Ascq by the NSL cluster on April 30, 2019
For more details (in French)
From 13 to 16 April 2019
29th ECCMID, Amsterdam, Netherlands
Meet us at the 29th European Congress of Clinical Microbiology & Infectious Diseases, in Amsterdam, Netherlands, from 13 - 16 April 2019.
Subcategories
Partners
At GenoScreen, our genomics expertise is built on collaboration with a dense network of scientific, industrial and institutional partners. These partnerships strengthen our ability to innovate, co-develop new technologies and advance research in molecular microbiology.
A network of strategic partners
We actively collaborate with:
Research institutes, universities and hospitals
Competitive clusters specialized in biotechnology and healthcare
Public funding bodies
A co-development strategy
Our research projects are carried out with recognized partners in France and abroad. Together, we can :
- Co-develop innovative genomics and bioinformatics solutions
- Reply to national and international applications for projects (Horizon Europe, ANR, etc.)
- Test and validate our technologies in a variety of environments
- Launch the implementation of concrete solutions for health, agriculture and the environment
Why collaborate with GenoScreen?
- Access to an innovative sequencing technology platform
- Access to recognized expertise in bioinformatics analysis and biomarkers
- Benefit from our ability to manage collaborative R&D projects
- Strive for health, agriculture and environment
Join our network of partners
Do you represent a company, laboratory or public body? Contact us to discuss a collaboration or partnership.
Frequently asked questions
What kind of partners work with GenoScreen?
GenoScreen works with academic laboratories, biotech companies and clusters.
What are the benefits of these partnerships?
They help us co-develop technologies, co-finance projects and accelerate innovation.
How can I propose a partnership?
You can contact us via our contact form to discuss your project and identify a potential collaboration.
Collaborative research - At the heart of international innovation in genomics
GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.
Our projects are designed to:
- Improve the diagnosis and management of acute/chronic diseases on humans and animals,
- Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.
The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.